Feeds:
Posts
Comments

Posts Tagged ‘Amantadine’

Lab created or otherwise,  the flu is spreading and mutating and it is not just the H1N1 Swine Flu. 

A new H3N2 variant has emerged that may be poorly matched to the 2009 seasonal influenza vaccine. This could pose a risk to the older population and to those who have been vaccinated against the pandemic strain [sic- just who has already been vaccinated for Swine, I’d like to know?]according to Univ Pitts biosecurity Network Support.  Since 1968, H3N2 has been the dominant strain in most influenza seasons. It has been implicated in more severe annual flu outbreaks than seasonal H1N1, and it harbors almost universal resistance to the adamantane class of drugs.  Over the past few months, the H3N2 virus has been accumulating genetic changes that may diminish the protectiveness of the seasonal influenza vaccine.   While information on the clinical illness caused by the H3N2 variant and the amount of protection conferred by the seasonal vaccine is not yet available, the fact that a vaccine mismatch might exist is worrisome.http://www.upmc-cbn.org/index.html

For over 30 years H3N2 is what has set off alarm bells in our bodies creating fever, diarrhea, nausea and vomiting.  People accepted the seasonal flu shot just as they will accept the new Swine Flu shot, but scientists are ringing the alarm bells that there is a new player coming to attack our bodies and that the flu shot could in fact have little benefit. 

“The emergence of this drifted variant of H3N2 underscores the vital need for continual surveillance of influenza isolates of all subtypes, as the propensity for this virus to alter its genetic components will also pose an obstacle to crafting efficacious vaccines.”  But there is no continual surveillance available to the public as the CDC and WHO have decided that it is no longer necessary to track H1N1 Swine Flu.  More importantly, the tests that are run to detect which virus is attacking is unreliable.  https://ahrcanum.wordpress.com/2009/05/03/swine-flu-influenza-a-h1n1-test-from-cdc-unreliable/

Yet, almost all governments are turning towards a mass vaccination campaign.  America was warned in January 2006.  ” High levels of resistance to the adamantane class of antiviral drugs (amantadine and rimantadine) exist in Wisconsin and elsewhere in the United States. Testing of 26 Wisconsin samples at the CDC has revealed a 96% rate of resistance. Amantadine and Rimantadine should not be used for influenza treatment of prophylaxis. The is no reported resistance to oseltamivir or zanamivir, but because of potential shortages, http://www.wha.org/qualityAndPatientSafety/pdf/flualert1-13-06.pdf  these drugs should be used judiciously.

Frig judiciousness.  For three or more years, scientists knew these drugs were not working and that there were indicators that there were viral mutations- yet shot after shot, drug after drug were manufactured and  administered.

“Resistance to the adamantane class of antiviral drugs by human A/H3N2 influenza viruses has increased dramatically in recent years, from a global prevalence of < 2% prior to 2002 to 12.3% in 2004, and currently > 90% in the United States and multiple Asian countries” http://www.themacraegroup.com/2009-symposia/xi-international-symposium-on-respiratory-viral-infections/oral-abstracts/the-global-emergence-and-evolution-of-adamantane-resistant-a-h3n2-influenza-viruses Greater than a 90% resistance rate! 

“Chinese farmers, acting with the approval and encouragement of government officials, have tried to suppress major bird flu outbreaks among chickens with an antiviral drug meant for humans, animal health experts said. International researchers now conclude that this is why the drug will no longer protect people in case of a worldwide bird flu epidemic.  http://www.washingtonpost.com/wp-dyn/content/article/2005/06/17/AR2005061701214.html cluck, cluck, the U.S. does not approve.

Global research is reporting that head of the main lab in Mexico that does influenza testing, told Science Insider that “There is no scientific evidence, up to date, that we have a different A (H1N1) virus other than human seasonal or swine-origin H1N1.” and that that proof of a “virus” associated with a novel swine flu strain is nonexistent. http://globalresearch.ca/index.php?context=va&aid=14603

Th U.S. government believe otherwise-

The newly emergent 2009 H1N1 influenza virus is a novel virus with pandemic potential. Consistent with the National Strategy for Pandemic Influenza, HHS is committing funds for the production of pilot lots for clinical studies, as well as a bulk supply of antigen and adjuvant for use in a potential vaccine for the 2009 H1N1 which will become a part of the national stockpile of pre-pandemic influenza vaccines.”

 

Manufacturer

Bulk Vaccine Antigen

Oil-In-Water Bulk Adjuvant

Novartis $150 million $139 million
GlaxoSmithKline $ 38 million $144 million
Sanofi Pasteur $191 million  
CSL Biotherapies $180 million  
MedImmune $ 90 million  
Total $649 million $283 million

 

Manufacturer

Bulk Vaccine Antigen

Bulk Virus Concentrate/FFF

Oil-In-Water Bulk Adjuvant

Sanofi Pasteur $61,425,000 0 0
GSK $0 0 $71,400,000
Novartis $346,334,450 0 $343,810,470
CSL $0 0 0
MedImmune $0 $61,008,000 0
Total $407,759,450 $61,008,000 $415,210,470

sourced at https://www.medicalcountermeasures.gov/BARDA/MCM/panflu/factsheet.aspx

flag toungeOpen wide, say ahhh and check out these previous posts on the A/H1N1 Swine Flu from Ahrcanum, where the conspiracy spreads as fast as the virus itself.

https://ahrcanum.wordpress.com/swine-flu-report/

Advertisements

Read Full Post »